Vimarsana
Biggest News Aggregation in the World

Page 34 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Pricing Program Today - Breaking & Trending Today

340B Anti-Discrimination Provisions: A Review of Proposed and Enacted Legislation by State | Manatt, Phelps & Phillips, LLP - Vimarsana News

340B Anti-Discrimination Provisions: A Review of Proposed and Enacted Legislation by State | Manatt, Phelps & Phillips, LLP

Editor’s Note: In a new survey, Manatt examines 340B anti-discrimination legislation in all 50 states. Highlights are below. For more information on accessing the full survey—available...

HRSA ADR Panel Dismisses NACHC's 340B Complaint Against Two Drug Manufacturers | Foley Hoag LLP - Vimarsana News

HRSA ADR Panel Dismisses NACHC's 340B Complaint Against Two Drug Manufacturers | Foley Hoag LLP

The 340B program requires drug manufacturers to offer outpatient pharmaceuticals to statutorily defined covered entities (including certain hospitals and certain federal grantees, such...

HRSA ADR Panel Dismisses NACHC's 340B Complaint Against Two Drug Manufacturers - Healthcare - Vimarsana News

HRSA ADR Panel Dismisses NACHC's 340B Complaint Against Two Drug Manufacturers - Healthcare

He 340B program requires drug manufacturers to offer outpatient pharmaceuticals to statutorily defined covered entities (including certain hospitals and certain federal...

Source: mondaq.com
Community health clinics set to lose critical $100M funding stream - Vimarsana News

Community health clinics set to lose critical $100M funding stream

A little-known federal initiative, the 340B Drug Pricing Program, supports services that wouldn’t otherwise get reimbursed.

Manchin, Braun Urge HHS to Crack Down on Pharmaceutical Companies Violating Affordable Medications Program - Vimarsana News

Manchin, Braun Urge HHS to Crack Down on Pharmaceutical Companies Violating Affordable Medications Program

September 29, 2022 Washington, DC – U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN) urged U.S. Department of Health and Human Services (HHS) Secretary